Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Placenta-Based Cell Therapy
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +22,65% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +22,65% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 53 | 01/11/06 |
Director of Finance/CFO | 40 | 01/05/13 | |
Zami Aberman
CHM | Chairman | 70 | 26/09/05 |
Artur Machlenkin
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Nitsan Halevy
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Lior Raviv
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Orly Amiran
PRN | Corporate Officer/Principal | - | - |
Nimrod Bar Zvi
PRN | Corporate Officer/Principal | - | - |
Efrat Kaduri
PRN | Corporate Officer/Principal | - | 01/10/14 |
Human Resources Officer | 62 | 01/01/07 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 73 | 15/07/21 | |
Zami Aberman
CHM | Chairman | 70 | 26/09/05 |
Yaky Yanay
CEO | Chief Executive Officer | 53 | 01/11/06 |
Director/Board Member | 54 | 06/01/21 | |
Director/Board Member | 62 | 01/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 5 388 792 | 4 204 128 ( 78,02 %) | 0 | 78,02 % |
Coordinate società
Pluri, Inc.
MATAM Advanced Technology Park Building No. 5
3508409, Haifa
+972 74 710 8600
http://www.pluri-biotech.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+22,10% | 46,55 Mrd | |
+46,45% | 41,84 Mrd | |
-3,12% | 40,84 Mrd | |
+36,10% | 32,95 Mrd | |
-6,30% | 28,27 Mrd | |
+18,71% | 27,78 Mrd | |
+46,15% | 14,26 Mrd | |
+44,52% | 13,69 Mrd | |
+0,19% | 12,18 Mrd |